Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Nussenbaum

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
JAMA Otolaryngology-- Head & Neck Surgery|September 11, 2025
Barriers and Timely Postoperative Radiation Therapy in Head and Neck CancerMegan T Nguyen, Emily Kistner-Griffin, Reid DeMass, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 6, 2024
Factors Associated with Head and Neck Cancer Postoperative Radiotherapy Delays: A Systematic Review and Meta-analysisKelsey A Duckett, Mohamed Faisal Kassir, Shaun A Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical TrialRavindra Uppaluri, Ashley E Winkler, Tianxiang Lin, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 25, 2024
Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck CancerEvan M Graboyes, Joshua Lee Cagle, Salma Ramadan, et al.
JCO Oncology Practice|January 6, 2025
Randomized Trial of Enhanced Versus Standard Navigation to Promote Timely Initiation of Adjuvant Radiotherapy for Head and Neck CancerEvan M Graboyes, Reid DeMass, Katherine R Sterba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2021
Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2020
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
JAMA Otolaryngology-- Head & Neck Surgery|September 11, 2025
Barriers and Timely Postoperative Radiation Therapy in Head and Neck CancerMegan T Nguyen, Emily Kistner-Griffin, Reid DeMass, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 6, 2024
Factors Associated with Head and Neck Cancer Postoperative Radiotherapy Delays: A Systematic Review and Meta-analysisKelsey A Duckett, Mohamed Faisal Kassir, Shaun A Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical TrialRavindra Uppaluri, Ashley E Winkler, Tianxiang Lin, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 25, 2024
Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck CancerEvan M Graboyes, Joshua Lee Cagle, Salma Ramadan, et al.
JCO Oncology Practice|January 6, 2025
Randomized Trial of Enhanced Versus Standard Navigation to Promote Timely Initiation of Adjuvant Radiotherapy for Head and Neck CancerEvan M Graboyes, Reid DeMass, Katherine R Sterba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2021
Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2020
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II TrialRavindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Pageof 14